Clinical Trial

Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

Name: Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain — clinical trial record (NCT07470606)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MemoryRT

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The study investigators are testing to see if patients receiving radiation treatment for brain cancer along with raloxifene plus memantidine take longer to develop memory issues. The study will include anyone over the age of 18 who will be treated with radiation for brain cancer.

Trial Details

NCT Number	NCT07470606
Lead Sponsor	The University of Texas Health Science Center at San Antonio
Conditions	Brain Tumor
Enrollment	108 participants
Start Date	2026-03
Primary Completion	2030-03 (estimated)
Study Completion	2031-03 (estimated)
Updated on ClinicalTrials.gov	2026-03-13